Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine presages an era of increased understanding of the molecular basis of cancer and of the ability to design treatments tailored to a patient’s own genetic profile, a panel of experts said Tuesday at a briefing sponsored by Columbia University.
If companies knew how much money could be saved by going green it might be easier to design products that use less energy, water, and other resources. That’s the idea behind new software developed at Columbia University, and expanded upon by CoClear, a Harlem-based startup.
Though it’s true that the committee has recommended dropping advice to limit cholesterol intake, eggs still have plenty of saturated fat and should be eaten in moderation, says David Seres, MD, associate professor of medicine and director of medical nutrition at Columbia University Medical Center.
Four P&S faculty members—Joy Vink, Nasir Naqvi, Max O’Donnell, and Sameer Sheth—have been named 2015 Gerstner Scholars. Every year since 2008, the Louis V. Gerstner Jr. Scholar Program has selected four young P&S physician-scientists to conduct translational research.
While diet and exercise are the usual suspects when it comes to the high numbers of obese children, new research is uncovering other factors, from an overabundance of fast food to a lack of green space.
Every pediatric cancer patient at Columbia University Medical Center benefits from genome sequencing of the tumor. Using technologies that have until now been largely restricted to research use and have taken many months to process, the Precision in Pediatric Sequencing (PIPseq) program provides results to the patient’s doctor in less than three weeks.
Columbia University Medical Center (CUMC) researchers have pinpointed the immune system mechanism that allows a kidney transplant to be accepted without lifelong immunosuppressive drugs, a significant step toward reducing or eliminating the need for costly and potentially toxic immunosuppressant drugs and improving long-term transplant success.